Cuatrecasas assists in $13.5bn financing for acquisition of Apotex
Cuatrecasas, through its Mexico City office, has assisted a syndicate of financial institutions, as Joint Lead Arrangers, on the Mexican law aspects of the approximately US$13.5 billion financing for SK Capital’s acquisition of the Apotex pharmaceutical group.
The Bank of Nova Scotia, RBC Capital Markets, TD Securities, HSBC Securities (USA), Truist Securities, Fédération des Caisses Desjardins du Québec and MUFG Bank Canada Branch acted as joint lead arrangers.
Apotex is a Canadian and global pharmaceutical company that produces high-quality, affordable medicines for patients around the world. The company employs nearly 8,000 people worldwide in manufacturing, research and development, and commercial operations. Apotex exports to more than 100 countries and territories, and operates in more than 45 countries, with a significant presence in Canada, the United States, Mexico and India.
Cuatrecasas’ team was led by partner León López (pictured), with support from lawyers Alberto de Villa and Ivana Muñiz.
